Natco gets USFDA tentative nod for generic Tamiflu

Natco Pharma today announced that it has received tentative approval from the US health regulator to sell generic version of Roche's Tamiflu, used to prevent and treat flu.

The tentative approval of Oseltamivir Phosphate (Tamiflu) capsules by the US Food and Drug Administration is for multiple strengths of 30mg, 45 mg and 75 mg, the company said in a filing to the BSE.

Natco may have first to file status for the abbreviated new drug application (ANDA), contingent upon successful litigation outcome of original drug patent 5,763,483.

The Hyderabad based company, citing IMS data, said Tamiflu had sales of approximately USD 495 million for the 12 months ending September 2013.

Shares of Natco Pharma were trading at Rs 832 per scrip in the afternoon trade, up 0.96 per cent from the previous close on the BSE.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Changes to FDI investment norms for housing look cosmetic

    The policy measures announced on Wednesday for facilitating greater participation of foreign direct investment (FDI) in the real estate sector do not

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Varun Dutt

Energy conservation through feedback

In households across the world, people use electric energy not ...

Zehra Naqvi

Rememberance and forgetting are crucial

Memories are so vital to our lives that they can ...

Dharmendra Khandal

Sandalwood may get extinct if not protected

When we talk of sandalwood, the most common usage that ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture